ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Confirmation of the Safety of Cryopreserved Human Cord Blood Derived Di-Chimeric Cells in the NSG Mouse Model.

J. Cwykiel, N. Filipek, E. Szilagyi, E. Tfaily, M. Siemionow.

Orthopaedics, University of Illinois at Chicago, Chicago, IL

Meeting: 2017 American Transplant Congress

Abstract number: D12

Keywords: Engraftment, Safety, Stem cells, Tolerance

Session Information

Session Name: Poster Session D: Cellular & Bone Marrow Transplantation Session II

Session Type: Poster Session

Date: Tuesday, May 2, 2017

Session Time: 6:00pm-7:00pm

 Presentation Time: 6:00pm-7:00pm

Location: Hall D1

Background: Cell therapies are a promising approach for tolerance induction in Vascularized Composite Allotransplantation (VCA). Thus, we have developed a new supportive therapy of ex vivo fused human cord blood-derived di-chimeric cells (DCC) for tolerance induction in VCA. This study aimed to establish cryopreservation conditions for long-term storage of DCC and evaluate the engraftment and safety of cryopreserved DCC in the NSG mouse model.

Methods: Sixteen fusions of human mononuclear cord blood cells (CBC) were performed. CBC from two unrelated donors were stained with PKH26 and PKH67 dyes and fused with polyethylene glycol. Double stained (PKH26/PKH67) DCC were sorted and cryopreserved in liquid nitrogen for 6 months using the following media: fetal bovine serum (FBS) with 10%DMSO, CryoStor®CS10 or StemSpanH3000 medium supplemented with 5%DMSO and 25[mu]g/ml trehalose. Assessment of DCC viability (Trypan Blue), apoptosis (Annexin V), proliferation (CFU assay), and changes in the DCC phenotype (CD4, CD25, CD34, CD90) by flow cytometry were evaluated at 90 days. The safety of cryopreserved DCC was tested in the NSG mouse model. Sixteen mice received either intramuscular (IM.) or intraosseous (IO.) injection of 0.5×10^6 of cryopreserved cells: Group 1-CBC (IM. delivery), Group 2-CBC (IO. delivery), Group 3-DCC (IM. delivery), and Group 4-DCC (IO. delivery). Mice were observed for changes in activity, posture and hair loss, evaluated for tissue changes by weekly palpations and at 90 days by magnetic resonance imaging (MRI). The presence of DCC in the recipients' blood was determined by HLA class I staining. Lymphoid organs, lungs, and liver were harvested at 90 days and assessed (H&E) for the presence of tumor-like growths.

Results: The highest viability of DCC was achieved using CryoStor®CS10 cryo-solution and lowest by FBS with 10% DMSO (15±5% of dead cells vs. 50%±15%). Cryopreserved DCC phenotype and proliferative properties were maintained. Following IO. delivery, DCCs (<1%) were observed at day 90 in the peripheral blood of the recipients. No DCC derived tumor-like growth was detected by MRI.

Conclusions: We have confirmed safety of DCC therapy and maintenance of parent cell phenotype after long-term storage. The unique concept of the created DCC line, representing phenotype characteristics of the transplant donor and recipient, is a new promising approach for tolerance induction in solid organ and VCA transplantation.

CITATION INFORMATION: Cwykiel J, Filipek N, Szilagyi E, Tfaily E, Siemionow M. Confirmation of the Safety of Cryopreserved Human Cord Blood Derived Di-Chimeric Cells in the NSG Mouse Model. Am J Transplant. 2017;17 (suppl 3).

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

To cite this abstract in AMA style:

Cwykiel J, Filipek N, Szilagyi E, Tfaily E, Siemionow M. Confirmation of the Safety of Cryopreserved Human Cord Blood Derived Di-Chimeric Cells in the NSG Mouse Model. [abstract]. Am J Transplant. 2017; 17 (suppl 3). https://atcmeetingabstracts.com/abstract/confirmation-of-the-safety-of-cryopreserved-human-cord-blood-derived-di-chimeric-cells-in-the-nsg-mouse-model/. Accessed June 2, 2025.

« Back to 2017 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences